Diisopropylethylamine → 5-Bromo-6-(3-methyl-oxetan-3-ylmethoxy)-pyridine-2-carboxylic acid (1-methyl-1-thiazol-2-yl-ethyl)-amide
反応式
[Br:1][C:2]1[CH:3]=[CH:4][C:5]([C:15]([OH:17])=O)=[N:6][C:7]=1[O:8][CH2:9][C:10]1([CH3:14])[CH2:13][O:12][CH2:11]1.[Cl-].COC1N=C(OC)N=C([N+]2(C)CCOCC2)N=1.CCN(C(C)C)C(C)C.[CH3:45][C:46]([CH3:53])([C:48]1[S:49][CH:50]=[CH:51][N:52]=1)[NH2:47]>CN(C=O)C>[CH3:45][C:46]([NH:47][C:15]([C:5]1[CH:4]=[CH:3][C:2]([Br:1])=[C:7]([O:8][CH2:9][C:10]2([CH3:14])[CH2:11][O:12][CH2:13]2)[N:6]=1)=[O:17])([C:48]1[S:49][CH:50]=[CH:51][N:52]=1)[CH3:53]参加物
6
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
To a solution of 5-bromo-6-(3-methyl-oxetan-3-ylmethoxy)-pyridine-2-carboxylic acid (Example 280b) (30 mg, 100 μmol) in dry DMF (1 ml) was added 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (29.1 mg, 105 μmol) and Hunig's base (52.4 uL, 300 umol). The reaction was stirred at r.t for 30 min, followed by addition of α,α-Dimethyl-2-thiazolemethanamine (Example 12c) (14.2 mg, 100 μmol). The reactions was stirred at room temperature overnight and monitored by LC-MS. When the reaction was complete, purification was directly done by preparative HPLC without any work-up procedure to give the title compound (9.8 mg, 23%). MS (EI): m/e=425.9 [M+H]+.
後処理
- stirringThe reactions was stirred at room temperature overnight
- custompurification
出典と根拠
- ORDレコード
- ord-244ae545ccd24deb8b6abc70bcebedb4
- 出典データセット
- uspto-grants-2016_04
- 特許番号
- US09321727B2
反応ノート
読み込み中…